WPI 1118 (Mirtazapine 30 mg)
Pill imprint WPI 1118 has been identified as Mirtazapine 30 mg.
Mirtazapine is used in the treatment of insomnia; major depressive disorder; anxiety; depression; hot flashes (and more), and belongs to the drug class tetracyclic antidepressants. Risk cannot be ruled out during pregnancy. Mirtazapine 30 mg is not a controlled substance under the Controlled Substance Act (CSA).
- 30 mg
- 13.00 mm
- Elliptical / Oval
- Prescription only
hypromellose 2910 (3 mPa.s)
hypromellose 2910 (6 mPa.s)
polyethylene glycol 400
ferric oxide yellow
|NDC Code||Manufacturer / Repackager|
|58016-0986||Southwood Pharmaceuticals Inc (repackager)|
|16590-0154||Stat RX USA LLC (repackager)|
|18837-0094||Innoviant Pharmacy Inc (repackager)|
|68258-7005||Dispensing Solutions Inc. (repackager)|
Note: Inactive ingredients may vary.
More about mirtazapine
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.